Metabolism of alcohol ethoxylates (AEs) in rat, hamster, and human hepatocytes and liver S9: a pilot study for metabolic stability, metabolic pathway, and metabolites identification in vitro and in silico

Quan Shi,Stefan Moors,James Dawick,Lauren Kavanagh,Theresa Neely,Yuan Tian,Birte Dreeßen,Juan-Carlos Carrillo,Holger Hein,Peter J. Boogaard

DOI: https://doi.org/10.1007/s00204-024-03761-y

2024-06-08

Archives of Toxicology

Abstract:Alcohol ethoxylates (AEs) are a well-known class of non-ionic surfactants widely used by the personal care market. The aim of this study was to evaluate and characterize the in vitro metabolism of AEs and identify metabolites. Five selected individual homologue AEs (C 8 EO 4 , C 10 EO 5 , C 12 EO 4 , C 16 EO 8 , and C 18 EO 3 ) were incubated using human, rat, and hamster liver S9 fraction and cryopreserved hepatocytes. LC–MS was used to identify metabolites following the incubation of AEs by liver S9 and hepatocytes of all three species. All AEs were metabolized in these systems with a half-life ranging from 2 to 139 min. In general, incubation of AE with human liver S9 showed a shorter half-life compared to rat liver S9. While rat hepatocytes metabolized AEs faster than human hepatocytes. Both hydrophobic alkyl chain and hydrophilic EO head group groups of AEs were found to be target sites of metabolism. Metabolites were identified that show primary hydroxylation and dehydrogenation, followed by O-dealkylation (shortening of EO head groups) and glucuronidation. Additionally, the detection of whole EO groups indicates the cleavage of the ether bond between the alkyl chain and the EO groups as a minor metabolic pathway in the current testing system. Furthermore, no difference in metabolic patterns of each individual homologue AE investigated was observed, regardless of alkyl chain length or the number of EO groups. Moreover, there is an excellent agreement between the in vitro experimental data and the metabolite profile simulations using in silico approaches (OECD QSAR Toolbox). Altogether, these data indicate fast metabolism of all AEs with a qualitatively similar metabolic pathway with some quantitative differences observed in the metabolite profiles. These metabolic studies using different species can provide important reference values for further safety evaluation.

toxicology

What problem does this paper attempt to address?

The paper aims to address the following issues:

1. **Metabolic Stability and Pathways**: Evaluate and characterize the in vitro metabolic stability of five selected alcohol ethers (AEs) and identify their metabolites. The subjects of study include C8EO4, C10EO5, C12EO4, C16EO8, and C18EO3.

2. **Inter-species Comparison**: Compare the metabolism of AEs in liver S9 and cryopreserved hepatocytes from different species (human, rat, and hamster) to explore the consistency of metabolic patterns across species.

3. **Metabolite Identification**: Identify the metabolites of AEs in different systems using liquid chromatography-mass spectrometry (LC-MS) and determine the major metabolic pathways, such as hydroxylation, dehydrogenation, O-dealkylation, and glucuronidation.

4. **Quantitative Structure-Activity Relationship Modeling**: Use the OECD QSAR Toolbox for quantitative structure-activity relationship (QSAR) modeling to predict the metabolic fate of AEs and compare it with experimental data.

Overall, this paper aims to comprehensively understand the metabolic characteristics of AEs and their inter-species differences through in vitro experiments and computational simulation methods, thereby providing important reference data for subsequent safety assessments.